Recent Progress in Light-Triggered Nanotheranostics for Cancer Treatment

Theranostics. 2016 Apr 27;6(7):948-68. doi: 10.7150/thno.15217. eCollection 2016.

Abstract

Treatments of high specificity are desirable for cancer therapy. Light-triggered nanotheranostics (LTN) mediated cancer therapy could be one such treatment, as they make it possible to visualize and treat the tumor specifically in a light-controlled manner with a single injection. Because of their great potential in cancer therapy, many novel and powerful LTNs have been developed, and are mainly prepared from photosensitizers (PSs) ranging from small organic dyes such as porphyrin- and cyanine-based dyes, semiconducting polymers, to inorganic nanomaterials such as gold nanoparticles, transition metal chalcogenides, carbon nanotubes and graphene. Using LTNs and localized irradiation in combination, complete tumor ablation could be achieved in tumor-bearing animal models without causing significant toxicity. Given their great advances and promising future, we herein review LTNs that have been tested in vivo with a highlight on progress that has been made in the past a couple of years. The current challenges faced by these LTNs are also briefly discussed.

Keywords: Nanoparticle; imaging; photodynamic; photothermal.; theranostics.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal
  • Light*
  • Nanoparticles / administration & dosage*
  • Neoplasms / diagnostic imaging*
  • Neoplasms / therapy*
  • Phototherapy / methods*
  • Theranostic Nanomedicine / methods*
  • Theranostic Nanomedicine / trends